885272-77-5

Basic information

• Product Name: 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE
• Synonyms: 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE
• CAS NO: 885272-77-5
• Molecular Formula: C₁₂H₁₁BrN₂O
• Molecular Weight: 279.13
• Mol File: 885272-77-5.mol

Chemical Properties

• Boiling Point: 410.2±55.0 °C(Predicted)
• Appearance: /
• Density: 1.470±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 6.98±0.20(Predicted)
• CAS DataBase Reference: 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE(885272-77-5)
• EPA Substance Registry System: 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE(885272-77-5)

Safety Data

• Hazardous Substances Data: 885272-77-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE is used as a chemical intermediate for the synthesis of various pharmaceuticals due to its potential biological activity. Its unique structure allows it to be a candidate for the development of new drugs targeting a range of medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE is used as a building block for designing and optimizing new molecules with therapeutic potential. Its presence in a compound can influence pharmacokinetic and pharmacodynamic properties, making it a valuable component in the creation of novel therapeutic agents.
Used in the Treatment of Medical Conditions:
Although further research is necessary to fully understand its properties and potential uses, 2-(4-BROMO-PHENYL)-4,5,6,7-TETRAHYDRO-OXAZOLO[4,5-C]PYRIDINE may have applications in the treatment of various medical conditions. Its heterocyclic nature suggests it could play a role in addressing specific biological targets or pathways relevant to disease treatment.
Note: The specific applications in different industries or for particular medical conditions are not provided in the materials. The above uses are inferred based on the general information about the compound's role in pharmaceutical research and development.

Upstream product

• 586-75-4 4-chlorobenzoyl chloride 
• 6320-39-4 3-aminopyridin-4-ol 
• 934331-04-1 2-(4-bromophenyl)[1,3]oxazolo[4,5-c]pyridine 
• 934331-03-0 C₁₂H₉BrN₂O₂ 
• 1354910-38-5 C₁₃H₁₀BrN₂O⁽¹⁺⁾*I^(1-) 
• 1017781-96-2 2-(4-bromo-phenyl)-5-methyl-4,5,6,7-tetrahydro-oxazolo[4,5-c]pyridine 

Downstream Products

• 1354910-14-7 4-[2-(4-bromo-phenyl)-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl]-butyric acid t-butyl ester 
• 1354910-36-3 2-(4-bromo-phenyl)-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-carboxylic acid t-butyl ester 
• 1354910-12-5 3-[2-(4-bromo-phenyl)-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl]-propionic acid t-butyl ester 
• 1354910-27-2 C₂₅H₂₄F₂N₂O₃ 
• 1354910-28-3 C₂₅H₂₆F₂N₂O₃ 
• 1354910-13-6 3-{2-[4-(benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-propionic acid t-butyl ester 
• 1354905-92-2 3-{2-[4-(benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-propionic acid 
• 1354910-15-8 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester 
• 1354906-02-7 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid 
• 1354910-18-1 tert-butyl 2-(4-hydroxyphenyl)-6,7-dihydrooxazolo[4,5-c]pyridine-5(4H)-carboxylate 
• 1354910-19-2 2-[4-(4-trifluoromethyl-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-carboxylic acid t-butyl ester 
• 1354910-40-9 2-[4-(4-trifluoromethyl-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS

The present invention relates to a fused heterocyclic derivative of the formula (I) The variables R1-R4, z, A, Q, X and Y are as defined in the claims. The following heterocycles are exemplified substructures of formula (I): The compounds of formula (I) are modulators of the S1P receptor (Sphingosine-1-phosphate receptor), More specifically, they are agonists of S1P5. The compounds have therapeutic use in treatment of cognitive disorders, age-relate cognitive decline and dementia.